APA (7th ed.) Citation

DJ, H., G, M., R, H., B, d. B., L, A., A, M., & G, J. (2016). Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34(11), e97. https://doi.org/10.1200/JCO.2013.50.1320

Chicago Style (17th ed.) Citation

DJ, Harding, MacQuillan G, Howman R, de Boer B, Adams L, Mitchell A, and Jeffrey G. "Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 11 (2016): e97. https://doi.org/10.1200/JCO.2013.50.1320.

MLA (9th ed.) Citation

DJ, Harding, et al. "Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 34, no. 11, 2016, p. e97, https://doi.org/10.1200/JCO.2013.50.1320.